Catalyst Wire Dossier Catalyst Wire Dossier
EMA guidance · 2012-02-17

European Medicines Agency concludes review of dose recommendations for anti-tuberculosis medicines used in children

View source ↗

Summary

EMA concludes a review of dose recommendations for anti-tuberculosis medicines used in children, providing updated dosing guidance.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications